“In every recession back to the 70s, generic or private label brands have grown share. We know it's going to be happen; it's happening in this recession. There is some trade down, there is obvious pocketbook pressure and frankly more consumers will try private label brands and retailer brands, than would try them in more normal economic times. The key is to minimize your losses and ideally continue to hold or continue to grow your share in that environment.

Where is there the most pressure? Generic drugs. And I think that's likely going to continue. One of the reasons that we are considering an exit from the Pharma businesses, because the Pharma business model, I think has the historical one that's worked so well i s in question and frankly that industry is going to be under more pressure from generic drugs.